| Michael Crum, MD | |
|
911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 | |
| (606) 430-3500 | |
| (606) 437-0595 |
| Full Name | Michael Crum |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 911 Bypass Rd Bldg A, Pikeville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912352030 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | ME140288 (Florida) | Secondary |
| 207P00000X | Emergency Medicine | 53315 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Hospital | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Lexington Clinic, Psc | 3476457532 | 310 |
News Archive
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.
Alkermes, Inc. today reported financial results for its first quarter of fiscal 2011, which ended on June 30, 2010.
Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain's ability to process information with lightning speed, according to a new study.
Scientists have discovered a previously unrecognized way that degradation can occur in silicone-urethane plastics that are often considered for use in medical devices. Their study, published in ACS' journal Macromolecules, could have implications for device manufacturers considering use of these plastics in the design of some implantable devices, including cardiac defibrillation leads.
› Verified 6 days ago
| Entity Name | New Lexington Clinic Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803681 PECOS PAC ID: 3476457532 Enrollment ID: O20031121000103 |
News Archive
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.
Alkermes, Inc. today reported financial results for its first quarter of fiscal 2011, which ended on June 30, 2010.
Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain's ability to process information with lightning speed, according to a new study.
Scientists have discovered a previously unrecognized way that degradation can occur in silicone-urethane plastics that are often considered for use in medical devices. Their study, published in ACS' journal Macromolecules, could have implications for device manufacturers considering use of these plastics in the design of some implantable devices, including cardiac defibrillation leads.
› Verified 6 days ago
| Entity Name | Pikeville Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.
Alkermes, Inc. today reported financial results for its first quarter of fiscal 2011, which ended on June 30, 2010.
Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain's ability to process information with lightning speed, according to a new study.
Scientists have discovered a previously unrecognized way that degradation can occur in silicone-urethane plastics that are often considered for use in medical devices. Their study, published in ACS' journal Macromolecules, could have implications for device manufacturers considering use of these plastics in the design of some implantable devices, including cardiac defibrillation leads.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Crum, MD Po Box 432, Pikeville, KY 41502-0432 Ph: (606) 430-3500 | Michael Crum, MD 911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 Ph: (606) 430-3500 |
News Archive
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.
Alkermes, Inc. today reported financial results for its first quarter of fiscal 2011, which ended on June 30, 2010.
Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain's ability to process information with lightning speed, according to a new study.
Scientists have discovered a previously unrecognized way that degradation can occur in silicone-urethane plastics that are often considered for use in medical devices. Their study, published in ACS' journal Macromolecules, could have implications for device manufacturers considering use of these plastics in the design of some implantable devices, including cardiac defibrillation leads.
› Verified 6 days ago
John M Fleming, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-0595 | |
William B Webb, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-0595 | |
Ashley Parsell, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 810 Hambley Blvd, Pikeville, KY 41501 Phone: 606-218-5354 | |
Elizabeth Dupre, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-218-3500 Fax: 606-437-0595 | |
James Derek Sword, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Road, Pikeville Medical Center Residency Program, Pikeville, KY 41501 Phone: 606-218-3985 Fax: 606-218-4620 | |
Christopher Cody Reynolds, D.O Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-0595 | |
Dr. Rasiah A Narendrakumar, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 Fax: 606-218-4697 |